{"meta":{"query_hash":"f52b97b8954c","filters":{"venue":"˜The œmedical letter on drugs and therapeutics/˜The œmedical letter"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f52b97b8954c","api":"https://metacan.xera.ac/api/v1/cohort?venue=%C2%98The+%C2%9Cmedical+letter+on+drugs+and+therapeutics%2F%C2%98The+%C2%9Cmedical+letter"},"results":[{"id":"W4393033073","doi":"10.58347/tml.2024.1696d","title":"Balfaxar: Another Four-Factor PCC for Warfarin Reversal","year":2024,"lang":"en","type":"article","venue":"˜The œmedical letter on drugs and therapeutics/˜The œmedical letter","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Warfarin; Medicine; Prothrombin complex concentrate; PROTHROMBIN COMPLEX; Factor IX; Internal medicine; Coagulation; Atrial fibrillation","score_opus":0.0607747322367431,"score_gpt":0.32304345620268404,"score_spread":0.2622687239659409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393033073","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010704,0.03240517,0.0025656936,0.8729122,0.028405774,0.000076127595,0.00013489352,0.00022647704,0.052569736],"genre_scores_gemma":[0.11964795,0.035246152,0.005201052,0.6922661,0.07598296,0.00016225898,0.00041008694,0.00011040151,0.070973046],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934775,0.0001683562,0.00007495568,0.000074952106,0.00025069958,0.000083315186],"domain_scores_gemma":[0.9989755,0.0003933774,0.00012346338,0.000055434783,0.00021132642,0.00024084296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065123563,0.00025822077,0.00037821743,0.0005645219,0.00069199473,0.0013442624,0.00037527253,0.0041721854,0.0049632387],"category_scores_gemma":[0.0031037647,0.00010816461,0.00053442206,0.00032949742,0.0010131487,0.0008682101,0.0005299718,0.0051355753,0.0027987263],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005081077,0.00021768968,0.0029821126,0.00027043466,0.000052530995,0.017417638,0.0002416205,0.00013001621,0.002995725,0.010821097,0.78466344,0.17969956],"study_design_scores_gemma":[0.00026491014,0.00023203655,0.0013636615,0.0002624048,0.000028158891,0.027470836,0.000079454854,0.00021142264,0.0013115448,0.0032682074,0.96548635,0.000021015248],"about_ca_topic_score_codex":0.0007649365,"about_ca_topic_score_gemma":0.0013265585,"teacher_disagreement_score":0.0049632387,"about_ca_system_score_codex":0.0011810885,"about_ca_system_score_gemma":0.00082161796,"threshold_uncertainty_score":0.016603708},"labels":[],"label_agreement":null}]}